LIKA
OSUGUI
Investigador/a en el periodo 2019-2019
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (3)
2022
-
Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells
Therapeutic Advances in Hematology, Vol. 13
2021
-
Co-administration of human MSC overexpressing HIF-1α increases human CD34+ cell engraftment in vivo
Stem Cell Research and Therapy, Vol. 12, Núm. 1
2019
-
The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34+ Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability
Stem Cells, Vol. 37, Núm. 10, pp. 1357-1368